ArticleBreast cancer research : BCR2025

Efficacy of everolimus in patients with hormone receptor positive, HER2 negative, metastatic breast cancer pretreated with CDK4/6 inhibitors.

Justine Dutheil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.